(+)-schisandrin B multiple interactions ISO Rras2 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RRAS2 mRNA] CTD PMID:31150632 1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of RRAS2 mRNA CTD PMID:26682919 1,2-dimethylhydrazine affects expression EXP 6480464 1 and 2-Dimethylhydrazine affects the expression of RRAS2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RRAS2 mRNA CTD PMID:22206623 1,3-dinitrobenzene increases expression ISO Rras2 (Rattus norvegicus) 6480464 3-dinitrobenzene results in increased expression of RRAS2 mRNA CTD PMID:22841810 1-naphthyl isothiocyanate multiple interactions ISO RRAS2 (Homo sapiens) 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of RRAS2 mRNA CTD PMID:27344345 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RRAS2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of RRAS2 mRNA CTD PMID:17942748 2,3',4,4',5-Pentachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of RRAS2 mRNA and [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RRAS2 mRNA CTD PMID:16214954 and PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Rras2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of RRAS2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of RRAS2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RRAS2 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RRAS2 mRNA CTD PMID:15328365 and PMID:18796159 2-(chloromethyl)pyridine increases expression ISO RRAS2 (Homo sapiens) 6480464 2-chloromethylpyridine results in increased expression of RRAS2 mRNA CTD PMID:26198647 2-butoxyethanol decreases expression EXP 6480464 n-butoxyethanol results in decreased expression of RRAS2 mRNA CTD PMID:19812364 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of RRAS2 mRNA CTD PMID:19285098 5-aza-2'-deoxycytidine affects expression ISO RRAS2 (Homo sapiens) 6480464 Decitabine affects the expression of RRAS2 mRNA CTD PMID:23300844 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression ISO Rras2 (Rattus norvegicus) 6480464 Omeprazole affects the expression of RRAS2 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression ISO Rras2 (Rattus norvegicus) 6480464 Propylthiouracil affects the expression of RRAS2 mRNA CTD PMID:19483382 6-propyl-2-thiouracil decreases expression ISO Rras2 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of RRAS2 mRNA CTD PMID:24780913 and PMID:30047161 acrylamide decreases expression ISO Rras2 (Rattus norvegicus) 6480464 Acrylamide results in decreased expression of RRAS2 mRNA CTD PMID:28959563 afimoxifene affects response to substance ISO RRAS2 (Homo sapiens) 6480464 RRAS2 gene affects the susceptibility to afimoxifene CTD PMID:21482774 aflatoxin B1 increases methylation ISO RRAS2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of RRAS2 gene CTD PMID:27153756 aflatoxin B1 increases expression ISO RRAS2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of RRAS2 mRNA CTD PMID:27153756 amiodarone affects expression ISO Rras2 (Rattus norvegicus) 6480464 Amiodarone affects the expression of RRAS2 mRNA CTD PMID:19483382 amitrole decreases expression ISO Rras2 (Rattus norvegicus) 6480464 Amitrole results in decreased expression of RRAS2 mRNA CTD PMID:30047161 antirheumatic drug increases expression ISO RRAS2 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of RRAS2 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RRAS2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of RRAS2 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RRAS2 (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to RRAS2 mRNA] CTD PMID:32406909 arsenous acid increases expression ISO RRAS2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of RRAS2 protein CTD PMID:25419056 azathioprine increases expression ISO RRAS2 (Homo sapiens) 6480464 Azathioprine results in increased expression of RRAS2 mRNA CTD PMID:26198647 benzbromarone affects expression ISO Rras2 (Rattus norvegicus) 6480464 Benzbromarone affects the expression of RRAS2 mRNA CTD PMID:19483382 benzo[a]pyrene increases expression ISO RRAS2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of RRAS2 mRNA CTD PMID:20064835 benzo[a]pyrene affects methylation ISO RRAS2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of RRAS2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of RRAS2 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of RRAS2 mRNA CTD PMID:19770486 benzo[a]pyrene diol epoxide I decreases expression ISO RRAS2 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 bis(2-chloroethyl) sulfide increases expression EXP 6480464 Mustard Gas results in increased expression of RRAS2 mRNA CTD PMID:18955075 bisphenol A increases expression ISO Rras2 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of RRAS2 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RRAS2 (Homo sapiens) 6480464 bisphenol A results in increased expression of RRAS2 protein CTD PMID:34186270 bisphenol A multiple interactions ISO RRAS2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of RRAS2 gene CTD PMID:31601247 bisphenol A decreases expression ISO RRAS2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of RRAS2 protein CTD PMID:33376534 and PMID:37567409 bisphenol A affects expression ISO RRAS2 (Homo sapiens) 6480464 bisphenol A affects the expression of RRAS2 mRNA CTD PMID:30903817 Bisphenol B increases expression ISO RRAS2 (Homo sapiens) 6480464 bisphenol B results in increased expression of RRAS2 protein CTD PMID:34186270 bisphenol F increases expression ISO RRAS2 (Homo sapiens) 6480464 bisphenol F results in increased expression of RRAS2 protein CTD PMID:34186270 cadmium dichloride increases methylation ISO Rras2 (Rattus norvegicus) 6480464 Cadmium Chloride results in increased methylation of RRAS2 promoter CTD PMID:22457795 capecitabine decreases response to substance ISO RRAS2 (Homo sapiens) 6480464 RRAS2 protein results in decreased susceptibility to Capecitabine CTD PMID:16734730 carbamazepine affects expression ISO RRAS2 (Homo sapiens) 6480464 Carbamazepine affects the expression of RRAS2 mRNA CTD PMID:24752500 and PMID:25979313 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 chenodeoxycholic acid multiple interactions ISO RRAS2 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RRAS2 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RRAS2 mRNA CTD PMID:32152650 cisplatin affects expression ISO RRAS2 (Homo sapiens) 6480464 Cisplatin affects the expression of RRAS2 mRNA CTD PMID:23300844 clofibrate affects expression ISO Rras2 (Rattus norvegicus) 6480464 Clofibrate affects the expression of RRAS2 mRNA CTD PMID:19483382 cobalt dichloride increases expression ISO RRAS2 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of RRAS2 mRNA CTD PMID:19376846 copper atom increases expression ISO Rras2 (Rattus norvegicus) 6480464 Copper results in increased expression of RRAS2 mRNA CTD PMID:22465980 copper atom multiple interactions ISO RRAS2 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of RRAS2 mRNA CTD PMID:30911355 copper(0) increases expression ISO Rras2 (Rattus norvegicus) 6480464 Copper results in increased expression of RRAS2 mRNA CTD PMID:22465980 copper(0) multiple interactions ISO RRAS2 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of RRAS2 mRNA CTD PMID:30911355 copper(II) sulfate increases expression ISO RRAS2 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of RRAS2 mRNA CTD PMID:19549813 Cuprizon increases expression ISO Rras2 (Rattus norvegicus) 6480464 Cuprizone results in increased expression of RRAS2 mRNA CTD PMID:27523638 cyclophosphamide increases expression ISO RRAS2 (Homo sapiens) 6480464 Cyclophosphamide results in increased expression of RRAS2 mRNA CTD PMID:17403535 cyclosporin A increases expression ISO RRAS2 (Homo sapiens) 6480464 Cyclosporine results in increased expression of RRAS2 mRNA CTD PMID:25562108 cyclosporin A multiple interactions ISO RRAS2 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RRAS2 mRNA CTD PMID:32152650 cyclosporin A decreases expression ISO RRAS2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of RRAS2 mRNA CTD PMID:27989131 deoxycholic acid multiple interactions ISO RRAS2 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RRAS2 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RRAS2 mRNA CTD PMID:32152650 dexamethasone increases expression ISO RRAS2 (Homo sapiens) 6480464 Dexamethasone results in increased expression of RRAS2 mRNA CTD PMID:25047013 dextran sulfate multiple interactions EXP 6480464 Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of RRAS2 protein] CTD PMID:32272095 dextran sulfate decreases expression EXP 6480464 Dextran Sulfate results in decreased expression of RRAS2 protein CTD PMID:32272095 diarsenic trioxide increases expression ISO RRAS2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of RRAS2 protein CTD PMID:25419056 diazinon increases expression ISO RRAS2 (Homo sapiens) 6480464 Diazinon results in increased expression of RRAS2 mRNA CTD PMID:26198647 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of RRAS2 mRNA CTD PMID:17361019 and PMID:21266533 diclofenac affects expression ISO RRAS2 (Homo sapiens) 6480464 Diclofenac affects the expression of RRAS2 mRNA CTD PMID:24752500 dicrotophos decreases expression ISO RRAS2 (Homo sapiens) 6480464 dicrotophos results in decreased expression of RRAS2 mRNA CTD PMID:28302478 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RRAS2 mRNA CTD PMID:30529165 doxifluridine decreases response to substance ISO RRAS2 (Homo sapiens) 6480464 RRAS2 protein results in decreased susceptibility to doxifluridine CTD PMID:16734730 ethanol affects expression EXP 6480464 Ethanol affects the expression of RRAS2 mRNA CTD PMID:30319688 fenthion decreases expression EXP 6480464 Fenthion results in decreased expression of RRAS2 mRNA CTD PMID:34813904 flutamide decreases expression ISO Rras2 (Rattus norvegicus) 6480464 Flutamide results in decreased expression of RRAS2 mRNA CTD PMID:24136188 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of RRAS2 mRNA CTD PMID:25629700 folic acid multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RRAS2 mRNA CTD PMID:22206623 FR900359 decreases phosphorylation ISO RRAS2 (Homo sapiens) 6480464 FR900359 results in decreased phosphorylation of RRAS2 protein CTD PMID:37730182 fulvestrant multiple interactions ISO RRAS2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of RRAS2 gene CTD PMID:31601247 gentamycin increases expression ISO Rras2 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of RRAS2 mRNA CTD PMID:22061828 and PMID:33387578 glycochenodeoxycholic acid multiple interactions ISO RRAS2 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RRAS2 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RRAS2 mRNA CTD PMID:32152650 glycocholic acid multiple interactions ISO RRAS2 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RRAS2 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RRAS2 mRNA CTD PMID:32152650 glycodeoxycholic acid multiple interactions ISO RRAS2 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RRAS2 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RRAS2 mRNA CTD PMID:32152650 hydrogen peroxide affects expression ISO RRAS2 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of RRAS2 mRNA CTD PMID:23410634 ivermectin decreases expression ISO RRAS2 (Homo sapiens) 6480464 Ivermectin results in decreased expression of RRAS2 protein CTD PMID:32959892 ketamine decreases expression ISO Rras2 (Rattus norvegicus) 6480464 Ketamine results in decreased expression of RRAS2 mRNA CTD PMID:20080153 L-ethionine affects expression ISO Rras2 (Rattus norvegicus) 6480464 Ethionine affects the expression of RRAS2 mRNA CTD PMID:19483382 lipopolysaccharide multiple interactions ISO RRAS2 (Homo sapiens) 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of RRAS2 mRNA CTD PMID:35877022 menadione increases expression ISO RRAS2 (Homo sapiens) 6480464 Vitamin K 3 results in increased expression of RRAS2 mRNA CTD PMID:23410634 methimazole decreases expression ISO Rras2 (Rattus norvegicus) 6480464 Methimazole results in decreased expression of RRAS2 mRNA CTD PMID:30047161 monosodium L-glutamate increases expression EXP 6480464 Sodium Glutamate results in increased expression of RRAS2 mRNA CTD PMID:22078008 monosodium L-glutamate multiple interactions EXP 6480464 [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of RRAS2 mRNA CTD PMID:22078008 N-methyl-4-phenylpyridinium multiple interactions ISO RRAS2 (Homo sapiens) 6480464 U 0126 affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of RRAS2 mRNA] CTD PMID:12710931 naphthalene increases expression EXP 6480464 naphthalene results in increased expression of RRAS2 mRNA CTD PMID:18978301 nefazodone multiple interactions ISO RRAS2 (Homo sapiens) 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RRAS2 mRNA CTD PMID:32152650 obeticholic acid increases expression ISO RRAS2 (Homo sapiens) 6480464 obeticholic acid results in increased expression of RRAS2 mRNA CTD PMID:27939613 omeprazole affects expression ISO Rras2 (Rattus norvegicus) 6480464 Omeprazole affects the expression of RRAS2 mRNA CTD PMID:19483382 oxaliplatin multiple interactions ISO Rras2 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of RRAS2 mRNA CTD PMID:25729387 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of RRAS2 mRNA CTD PMID:17562736 paracetamol increases expression ISO Rras2 (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of RRAS2 mRNA CTD PMID:33387578 perfluorooctane-1-sulfonic acid affects expression EXP 6480464 perfluorooctane sulfonic acid affects the expression of RRAS2 mRNA CTD PMID:19429403 perfluorooctanoic acid affects expression EXP 6480464 perfluorooctanoic acid affects the expression of RRAS2 mRNA CTD PMID:19429403 phenobarbital affects expression ISO RRAS2 (Homo sapiens) 6480464 Phenobarbital affects the expression of RRAS2 mRNA CTD PMID:19159669 pirinixic acid affects expression ISO Rras2 (Rattus norvegicus) 6480464 pirinixic acid affects the expression of RRAS2 mRNA CTD PMID:19483382 pirinixic acid multiple interactions ISO RRAS2 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RRAS2 mRNA CTD PMID:19710929 pyrogallol increases expression EXP 6480464 Pyrogallol results in increased expression of RRAS2 mRNA CTD PMID:20362636 rimonabant multiple interactions EXP 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of RRAS2 mRNA] CTD PMID:19030233 SB 431542 multiple interactions ISO RRAS2 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RRAS2 protein CTD PMID:37664457 silver atom increases expression ISO RRAS2 (Homo sapiens) 6480464 Silver results in increased expression of RRAS2 mRNA CTD PMID:26551752 silver(0) increases expression ISO RRAS2 (Homo sapiens) 6480464 Silver results in increased expression of RRAS2 mRNA CTD PMID:26551752 sodium arsenite increases expression ISO RRAS2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of RRAS2 mRNA CTD PMID:17879257 and PMID:20886546 sodium arsenite decreases expression ISO Rras2 (Rattus norvegicus) 6480464 sodium arsenite results in decreased expression of RRAS2 mRNA CTD PMID:35314868 sunitinib decreases expression ISO RRAS2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of RRAS2 mRNA CTD PMID:31533062 temozolomide increases expression ISO RRAS2 (Homo sapiens) 6480464 Temozolomide results in increased expression of RRAS2 mRNA CTD PMID:31758290 tert-butyl hydroperoxide increases expression ISO RRAS2 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of RRAS2 mRNA CTD PMID:23410634 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of RRAS2 mRNA CTD PMID:27339419 and PMID:31919559 tetrachloromethane increases expression ISO Rras2 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of RRAS2 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO Rras2 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RRAS2 mRNA] CTD PMID:31150632 thioacetamide affects expression ISO Rras2 (Rattus norvegicus) 6480464 Thioacetamide affects the expression of RRAS2 mRNA CTD PMID:19483382 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of RRAS2 mRNA CTD PMID:23557971 topotecan multiple interactions ISO Rras2 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of RRAS2 mRNA CTD PMID:25729387 topotecan increases expression ISO Rras2 (Rattus norvegicus) 6480464 Topotecan results in increased expression of RRAS2 mRNA CTD PMID:25729387 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of RRAS2 mRNA CTD PMID:19042947 trimethyltin increases expression EXP 6480464 trimethyltin results in increased expression of RRAS2 mRNA CTD PMID:20833246 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of RRAS2 mRNA CTD PMID:17963808 valproic acid affects expression ISO RRAS2 (Homo sapiens) 6480464 Valproic Acid affects the expression of RRAS2 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RRAS2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of RRAS2 mRNA CTD PMID:29154799 vinclozolin decreases expression ISO Rras2 (Rattus norvegicus) 6480464 vinclozolin results in decreased expression of RRAS2 mRNA CTD PMID:23034163 zoledronic acid increases expression ISO RRAS2 (Homo sapiens) 6480464 zoledronic acid results in increased expression of RRAS2 protein CTD PMID:28871336
